← All trials
NCT04437875
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 17, 2020
- Primary completion
- Aug 5, 2020
- Completion date
- Aug 15, 2020
- First posted
- Jun 18, 2020
- Last posted
- Jun 18, 2020
- Enrollment
- 38
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Government of RussiaLead sponsor
- I.M. Sechenov First Moscow State Medical UniversityOverall official - principal investigator
- Acellena Contract Drug Research and DevelopmentCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.